Skip to main content
. 2015 Feb 21;21(7):2080–2088. doi: 10.3748/wjg.v21.i7.2080

Table 5.

Correlations between serum soluble heparin-binding epidermal growth factor-like growth factor and clinicopathological characteristics of each group

Clinicopathological characteristics Serum sHB-EGF Serum CEA
γs (P value) γs (P value)
Age (yr)1 -0.265 (0.001) -0.087 (0.275)
Sex (male:female) 0.138 (0.076) -0.021 (0.792)
H. pylori infection (-/+) -0.054 (0.486) -0.114 (0.151)
Histology (well:mod:poorly:signet) 0.214 (0.078) 0.090 (0.465)
Tumor location (lower:middle:upper) -0.052 (0.652) -0.048 (0.691)
T-stage (T1a:T1b:T2:T3:T4) 0.669 (< 0.001) 0.201 (0.101)
N-stage (N0:N1:N2:N3) 0.407 (0.001) 0.073 (0.552)
Distant metastasis (M0:M1) 0.261 (0.030) 0.328 (0.006)
Overall stage (I:II:III:IV) 0.570 (< 0.001) 0.229 (0.060)
Size of tumor (< 3 cm; 3-5 cm and > 5 cm)2 0.237 (0.048) 0.362 (0.002)
1

This value is continuous variable. Thus, correlation is evaluated by Pearson’s correlation (γp).

2

Subjects were classified into three groups according to primary GC size: < 3 cm, 3-5 cm, and > 5 cm to analyze the relationship between serum HB-EGF levels and primary GC size. CEA: Carcinoembryonic antigen; H. pylori: Helicobacter pylori; Mod: Moderate-differentiated carcinoma; Poorly: Poorly-differentiated carcinoma; Signet: Signet ring cell carcinoma; sHB-EGF: Soluble heparin-binding EGF-like growth factor; Well: Well-differentiated carcinoma; γs: Spearman’s correlation coefficient. P < 0.05 (two-tailed) was considered statistically significant. Statistically significant values are given in bold print.